Views

CrossRef citations to date

Altmetric

Letters to the Editor

Effect of post-treatment MRD status on subsequent outcomes according to chemotherapy intensity in acute myeloid leukemia (AML)

Michael J. Hochmana Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA

Megan Othusa Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA;b Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

Roland B. Waltera Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA;b Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

Carole Shawb Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

Kelda Gardnera Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA

Mary-Elizabeth M. Percivala Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA;b Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

https://orcid.org/0000-0002-7016-951X

Anna B. Halperna Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA;b Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

Paul C. Hendriea Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA

Brenda M. Sandmaiera Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA;b Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

https://orcid.org/0000-0002-9767-9739

Elihu H. Esteya Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA;b Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USACorrespondence[email protected]

show all

Click to increase image sizeClick to decrease image size

Author contributions

Michael J. Hochman, Megan Othus, and Elihu H. Estey designed the research, performed the analyses, and wrote the paper. Carole Shaw and Kelda Gardner provided data for the analyses. Roland B. Walter, Mary-Elizabeth M. Percival, Anna B. Halpern, Paul C. Hendrie, and Brenda M. Sandmaier reviewed the letter and made suggestions. All authors approved the final submission.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Effect of post-treatment MRD status on subsequent outcomes according to chemotherapy intensity in acute myeloid leukemia (AML)

Information for

Open access

Opportunities

Help and information

Effect of post-treatment MRD status on subsequent outcomes according to chemotherapy intensity in acute myeloid leukemia (AML)

Author contributions

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature